Gamida Cell's US-listed shares down after naming new finance chief

Gamida Cell

22/05/2023 15:09

** U.S.-listed shares of Israeli cancer therapy developer
Gamida Cell Ltd  GMDA.O  down 1% at $2.03
    ** Company says Shai Lankry, chief financial office of five
years, to step down
    ** Names Terry Coelho as CFO, effective immediately
    ** Coelho currently serves as independent director on boards
of First Wave BioPharma  FWBI.O  and HOOKIPA Pharma  HOOK.O 
    ** Gamida's U.S.-listed shares up 57.5% YTD

 (Reporting by Vaibhav Sadhamta)
 ((Vaibhav.Sadhamta@thomsonreuters.com))